Petulant is the word I have used often to describe his agitation on many calls I have witnessed. Clearly the patterson issue, whatever that really is, remains stuck in his craw.

My contention remains firm, staying cool with the FDA is way better for shareholders than picking fights with patterson about shitte we don't know much about.